These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
9. IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15-hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor gamma transcription factor. Shankaranarayanan P; Nigam S J Immunol; 2003 Jan; 170(2):887-94. PubMed ID: 12517954 [TBL] [Abstract][Full Text] [Related]
10. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. Avis I; Hong SH; Martinez A; Moody T; Choi YH; Trepel J; Das R; Jett M; Mulshine JL FASEB J; 2001 Sep; 15(11):2007-9. PubMed ID: 11511519 [TBL] [Abstract][Full Text] [Related]
11. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY. Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050 [TBL] [Abstract][Full Text] [Related]
12. The role of mitogen-activated protein kinases and their relationship with NF-kappaB and PPARgamma in indomethacin-Induced apoptosis of colon cancer cells. Kim TI; Jin SH; Kang EH; Shin SK; Choi KY; Kim WH Ann N Y Acad Sci; 2002 Nov; 973():241-5. PubMed ID: 12485869 [TBL] [Abstract][Full Text] [Related]
13. 12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cells. Gu J; Wen Y; Mison A; Nadler JL Endocrinology; 2003 Feb; 144(2):534-43. PubMed ID: 12538614 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R; Iñiguez MA; Fresno M Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. Chen F; Wang M; O'Connor JP; He M; Tripathi T; Harrison LE J Cell Biochem; 2003 Nov; 90(4):732-44. PubMed ID: 14587029 [TBL] [Abstract][Full Text] [Related]
18. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Chen ZY; Tseng CC Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033 [TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage. Xu R; Wang S; Li W; Liu Z; Tang J; Tang X J Neurosurg; 2017 Sep; 127(3):522-531. PubMed ID: 27739938 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: binding and activation by an aromatic fatty acid with clinical antitumor activity. Samid D; Wells M; Greene ME; Shen W; Palmer CN; Thibault A Clin Cancer Res; 2000 Mar; 6(3):933-41. PubMed ID: 10741718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]